I

InfuSystem Holdings Inc
AMEX:INFU

Watchlist Manager
InfuSystem Holdings Inc
AMEX:INFU
Watchlist
Price: 8.86 USD -1.01% Market Closed
Market Cap: 188.1m USD
Have any thoughts about
InfuSystem Holdings Inc?
Write Note

Net Margin
InfuSystem Holdings Inc

1.1%
Current
1%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.1%
=
Net Income
1.5m
/
Revenue
132.8m

Net Margin Across Competitors

Country US
Market Cap 188.1m USD
Net Margin
1%
Country US
Market Cap 94.1B USD
Net Margin
1%
Country US
Market Cap 88.8B EUR
Net Margin
1%
Country US
Market Cap 75.4B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.2B USD
Net Margin
3%
Country DE
Market Cap 18.7B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.5B EUR
Net Margin
3%
Country AU
Market Cap 13.7B AUD
Net Margin
6%
No Stocks Found

InfuSystem Holdings Inc
Glance View

Market Cap
188.1m USD
Industry
Health Care

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

INFU Intrinsic Value
10.8 USD
Undervaluation 18%
Intrinsic Value
Price
I

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.1%
=
Net Income
1.5m
/
Revenue
132.8m
What is the Net Margin of InfuSystem Holdings Inc?

Based on InfuSystem Holdings Inc's most recent financial statements, the company has Net Margin of 1.1%.